Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001213900-20-015161
Filing Date
2020-06-17
Accepted
2020-06-17 10:47:08
Documents
1
Effectiveness Date
2020-06-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12634
  Complete submission text file 0001213900-20-015161.txt   13997
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-369118 | Film No.: 20968445
SIC: 2834 Pharmaceutical Preparations